Dev114629 743..752

نویسندگان

  • Manuel Stemmer
  • Laura-Nadine Schuhmacher
  • Nicholas S. Foulkes
  • Cristiano Bertolucci
  • Joachim Wittbrodt
چکیده

The troglomorphic phenotype shared by diverse cave-dwelling animals is regarded as a classical example of convergent evolution. One unresolved question is whether the characteristic eye loss in diverse cave species is based on interference with the same genetic program. Phreatichthys andruzzii, a Somalian cavefish, has evolved under constant conditions in complete darkness and shows severe troglomorphic characteristics, such as complete loss of eyes, pigments and scales. During early embryonic development, a complete eye is formed but is subsequently lost. In Astyanax mexicanus, another blind cavefish, eye loss has been attributed to interference during eye field patterning. Toaddresswhether similar pathwayshavebeen targetedby evolution independently, we investigated the retinal development of P. andruzzii, studying the expression of marker genes involved in eye patterning, morphogenesis, differentiation and maintenance. In contrast to Astyanax, patterning of the eye field and evagination of the optic vesicles proceeds without obvious deviation. However, the subsequent differentiation of retinal cell types is arrested during generation of the first-born cell type, retinal ganglion cells, which also fail to project correctly to the optic tectum. Eye degeneration in both species is driven by progressive apoptosis. However, it is retinal apoptosis in Phreatichthys that progresses in a wave-like manner and eliminates progenitor cells that fail to differentiate, in contrast to Astyanax, where lens apoptosis appears to serve as a driving force. Thus, evolutionhas targeted late retinaldifferentiationevents, indicating that there are several ways to discontinue the development and maintenance of an eye.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

United States Patent Marti

CPC B05D 31107 (2013.01); B05D 1118 (2013.01); B05D 5100 (2013.01); B05D 7124 (2013.01); B82Y 30100 (2013.01); B82Y 40100 (2013.01); C01B 31100 (2013.01); C01B 3110246 (2013.01); C01B 3110273 (2013.01); COJB 2202/02 (2013.01); COJB 2202/04 (2013.01); COJB 2202/06 (2013.01); COJB 2202/30 (2013.01); COJB 2202/34 (2013.01); COJB 2202/36 (2013.01); YJOS 977/742 (2013.01); YJOS 977/743 (2013.01); YJ...

متن کامل

Rules of Conduct and Principles of Adjudication

I. Rules of Conduct and Principles of Adjudication: The Distinction and Its Implications .............. 730 II. Rules of Conduct and Principles of Adjudication in Current Doctrine ................................ 733 A. The Distinction Applied to Current Doctrine.. 733 1. Objective elements of an offense .......... 733 2. Secondary prohibitions .................. 734 3. State of mind elements ....

متن کامل

Differential cytostatic and apoptotic effects of ecteinascidin-743 in cancer cells. Transcription-dependent cell cycle arrest and transcription-independent JNK and mitochondrial mediated apoptosis.

We have found that ecteinascidin-743 (ET-743) inhibited cell proliferation at 1-10 ng/ml, leading to S and G(2)/M arrest and subsequent apoptosis, and induced early apoptosis without previous cell cycle arrest at 10-100 ng/ml in cancer cells. ET-743-mediated apoptosis, did not involve Fas/CD95. ET-743 induced c-Jun NH(2)-terminal kinase (JNK) and caspase-3 activation, and JNK and caspase inhibi...

متن کامل

The importance of microglia in the development of the vasculature in the central nervous system

The body's vascular system is thought to have developed in order to supply oxygen and nutrients to cells beyond the reach of simple diffusion. Hence, relative hypoxia in the growing central nervous system (CNS) is a major driving force for the ingression and refinement of the complex vascular bed that serves it. However, even before the establishment of this CNS vascular system, CNS-specific ma...

متن کامل

Sequence-dependent enhancement of cytotoxicity produced by ecteinascidin 743 (ET-743) with doxorubicin or paclitaxel in soft tissue sarcoma cells.

Ecteinascidin 743 (ET-743) is a potent antitumor agent from the Caribbean tunicate Ecteinascidin turbinata and is presently in clinical trials for human cancers. To better understand how ET-743 might be used clinically, the present study used SRB assays to examine the cytotoxicity resulting from combining ET-743 with three other antineoplastic agents: doxorubicin (DXR), trimetrexate, and paclit...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2015